ScholarWorks@Gachon: Shin, Mi Seung

Detailed Information

Shin, Mi Seung (신미승)

College of Medicine (Department of Medicine)

Research Area

Tel 032-460-3054
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Heart failure:18||Echocardiography:11||heart failure:9||sex:5||Coronary artery disease:5||Cardiovascular disease:5||Prognosis:5||coronary artery disease:5||Obesity:5||Hypertension:4||Women:4||Mortality:4||blood pressure:4||Diastolic function:4||hypertension:3||Hospitalization:3||Coronary angiography:3||Pregnancy:3||chest pain:3||Normal population:3||depression:3||Reference value:3||Metabolic syndrome:2||advance care planning:2||advance directive:2||implantable cardioverterdefibrillator:2||Coronary artery stenosis:2||Guideline:2||Acute heart failure:2||Atrial fibrillation:2||Awareness:2||Heart Failure:2||metabolic syndrome:2||NTproBNP:2||Chest pain:2||Cognitive function:2||cognitive function:2||Palliative care:2||Advance directives:2||prognosis:2||Epicardial adipose tissue:2||Diagnosis:2||selfcare:2||diastolic dysfunction:2||diastolic function:2||Exercise capacity:2||ejection fraction:2||symptoms:2||Treatment:2||Type 2 diabetes:2||Hypertriglyceridemia:1||Hypertrophic cardiomyopathy:1||IVUS:1||Implantable cardioverterdefibrillator:1||Independent predictor:1||Intravascular ultrasound:1||Knowledge:1||Korea:1||Korean Acute Heart Failure Registry:1||LA function:1||LA strain:1||Left Ventricular Reverse Remodeling:1||Left main disease:1||Left ventricular hypertrophy:1||Left ventricular mass:1||Left ventricular outflow obstruction:1||Left ventricular outflow tract obstruction:1||Lifesustaining treatment:1||Long QT syndrome:1||Management guideline:1||Marfan syndrome:1||Mean pulmonary artery pressure:1||Medical conditions:1||Menopause:1||Mesenteric vascular occlusion:1||Morgagni hernia:1||Myocardial Infarction:1||Myocardial infarction:1||Nterminal proB type natriuretic peptide:1||Nterminal probrain natriuretic peptide:1||Neprilysin:1||Neural modulation:1||Noncardiac surgery:1||Operations:1||Overall obesity:1||Overweight:1||Paclitaxeleluting stent:1||Paradoxical embolism:1||Parity:1||Patent foramen ovale:1||Peripartum cardiomyopathy:1||Physical function:1||Postmenopausal women:1||Prevalence:1||Pulmonary embolism:1||Pulmonary hypertension:1||Q methodology:1||QRS duration:1||QT prolongation:1||Race:1||Registry:1||Right ventricle:1||SGLT2 inhibition:1||ST elevation myocardial infarction (STEMI):1||Sex Factors:1||Sex characteristics:1||Sex differences:1||Sirolimuseluting stent:1||Sodiumglucose cotransporter 2:1||Speckletracking echocardiography:1||Statin:1||Strain:1||Tachycardia, ventricular:1||Target organ damage:1||Threevessel disease:1||Tissue Doppler:1||Torsades de Pointes:1||Transthoracic echocardiography:1||Treatment outcomes:1||Trial design:1||Troponin:1||Woman:1||amlodipine:1||angiotensin II type 1 receptor blockers:1||angiotensin receptor blockers:1||antihypertensive:1||anxiety:1||attitudes:1||betablocker:1||blood pressure measurements:1||blood pressure variability:1||cardiovascular disease:1||cardiovascular diseases:1||caregivers:1||carvedilol:1||central hemodynamics:1||chronic kidney disease:1||cluster analysis:1||combination:1||communication:1||coronary angiography:1||diabetes mellitus:1||diabetes mellitus, type 2:1||diastolic strain rate:1||dyslipidemia:1||fimasartan:1||functional status:1||gelatin powder:1||gender:1||gender bias:1||health perception:1||healthrelated quality of life:1||heart failure with preserved ejection fraction:1||hematocrit:1||hospitalization:1||ischaemic heart disease:1||kidney diseases:1||knowledge:1||left ventricle:1||left ventricular systolic dysfunction:1||losartan:1||lowdensity lipoprotein cholesterol:1||monitoring:1||morbidity:1||mortality:1||normal reference:1||nurse:1||observational study:1||omega3:1||palliative care:1||parity:1||patients:1||percutaneous coronary intervention:1||perspectives:1||physical function:1||physician:1||postmenopause:1||pregnancy:1||randomized controlled trials:1||risk factor:1||sector probe:1||sex difference:1||signs and symptoms:1||singlepill combination:1||sodiumglucose transporter 2:1||stable angina:1||stroke:1||target organ damage:1||treatment outcome:1||type 2 diabetes mellitus:1||ultrasound gel:1||ultrasound test soft solid gel (ATS539):1||women:1||과체중:1||관리지침:1||비만:1||심부전:1||심초음파검사:1||우심실:1||이완기능:1||좌심실 충만압:1||진단:1||Advance care planning:1||Advance directive:1||Angina pectoris:1||Angiotensin converting enzyme inhibitor:1||Angiotensin receptor inhibitor:1||Anxiety:1||Apparent treatment resistant hypertension:1||Atorvastatin:1||Atrial and ventricular arrhythmia:1||Attitude:1||Attitudes:1||Beta Blocker:1||Bisoprolol:1||Body mass index:1||Cardiac events:1||Cardiac mass:1||Cardiomyopathies:1||Central obesity:1||Cha2ds2vasc score:1||Characteristics:1||Chronic heart failure:1||Complications:1||Coronary vasospasm:1||Coronary vessel anomalies:1||Death:1||Delphi technique:1||Depressive symptoms:1||Diabetes mellitus:1||Diaphragmatic hernia:1||Diastolic dysfunction:1||Dobutamine stress:1||Dobutamine stress echocardiography:1||Doppler:1||Dyspnea:1||Early repolarization (ER):1||Edge vascular response:1||Electrocardiography:1||Exercise:1||Exercisestress electrocardiography:1||Fatty acids:1||Functional capacity:1||Gender:1||Health behavior:1||Health perception:1||Heart Rate:1||Heart disease:1||Hiatal hernia:1||High risk pregnancy:1||Hypertension Resistant to Conventional Therapy:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE